Lecanemab for Alzheimer's disease: tempering hype and hope. The Lancet. Lancet 2022;400:1899.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

The Lancet. Lecanemab for Alzheimer's disease: tempering hype and hope. Lancet 2022;400:1899.
PMID: 36463893